Early-Pregnancy Plasma Concentrations of Perfluoroalkyl Substances and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics?

American Journal of Epidemiology

Volumn 187, Issue 4, 2018, Pages 793-802

  Sagiv, Sharon K ^a,b   Rifas Shiman, Sheryl L ^c   Fleisch, Abby F ^d,e   Webster, Thomas F ^f   Calafat, Antonia M ^g   Ye, Xiaoyun ^g   Gillman, Matthew W ^h   Oken, Emily ^c,i  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MAINE MEDICAL CENTER   (United States)

^e Maine Medical Center Research Institute   (United States)

^f BOSTON UNIVERSITY   (United States)

^g NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^h Environmental Influences on Child Health Outcomes   (United States)

ⁱ HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

birth weight; fetal growth; gestational age; perfluoroalkyl substances; pregnancy; preterm birth

Indexed keywords

ALBUMIN; CREATININE; PERFLUORONONANOIC ACID; PERFLUOROOCTANESULFONIC ACID; ALKANESULFONIC ACID; FLUOROCARBON; HEXADECAFLUORO-NONANOIC ACID; SERUM ALBUMIN;

BIOMARKER; BIRTH RATE; CHEMICAL SUBSTANCE; CONCENTRATION (COMPOSITION); CONFIDENCE INTERVAL; PHYSIOLOGY; PREGNANCY; PROTEIN; WOMENS HEALTH;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; BLOOD LEVEL; COHORT ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA VOLUME; PREGNANCY OUTCOME; PREMATURE LABOR; PROSPECTIVE STUDY; SCORING SYSTEM; SEX FACTOR; BLOOD; DRUG EFFECT; FETUS DEVELOPMENT; MASSACHUSETTS; MATERNAL EXPOSURE; PHYSIOLOGY; POLLUTANT; PREGNANCY; PRENATAL EXPOSURE; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

MASSACHUSETTS; UNITED STATES;

ADULT; ALKANESULFONIC ACIDS; BIRTH WEIGHT; CREATININE; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEVELOPMENT; FLUOROCARBONS; GESTATIONAL AGE; HEMODYNAMICS; HUMANS; MASSACHUSETTS; MATERNAL EXPOSURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SERUM ALBUMIN; SOCIOECONOMIC FACTORS;

EID: 85042329171     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwx332     Document Type: Article

References (52)

1. Olsen GW, Burris JM, Ehresman DJ, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007;115(9):1298-1305.
2. Calafat AM, Kuklenyik Z, Reidy JA, et al. Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES). Environ Sci Technol 2007; 41(7):2237-2242.
3. Calafat AM, Wong LY, Kuklenyik Z, et al. Polyfluoroalkyl chemicals in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 2007;115(11):1596-1602.
4. Lau C, Butenhoff JL, Rogers JM. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 2004;198(2):231-241.
5. Olsen GW, Butenhoff JL, Zobel LR. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod Toxicol 2009; 27(3-4):212-230.
6. Fei C, McLaughlin JK, Tarone RE, et al. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 2007;115(11):1677-1682.
7. Apelberg BJ, Witter FR, Herbstman JB, et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007;115(11):1670-1676.
8. Maisonet M, Terrell ML, McGeehin MA, et al. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ Health Perspect 2012;120(10):1432-1437.
9. Chen MH, Ha EH, Wen TW, et al. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One 2012;7(8):e42474.
10. WuK, Xu X, Peng L, et al. Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes. Environ Int 2012;48:1-8.
11. Stein CR, Savitz DA, Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 2009;170(7):837-846.
12. Washino N, Saijo Y, Sasaki S, et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ Health Perspect 2009;117(4):660-667.
13. Wang Y, Adgent M, Su PH, et al. Prenatal exposure to perfluorocarboxylic acids (PFCAs) and fetal and postnatal growth in the Taiwan Maternal and Infant Cohort Study. Environ Health Perspect 2016;124(11):1794-1800.
14. de Cock M, De Boer MR, Lamoree M, et al. Prenatal exposure to endocrine disrupting chemicals and birth weight-a prospective cohort study. J Environ Sci Health A Tox Hazard Subst Environ Eng 2016;51(2):178-185.
15. Bach CC, Bech BH, Nohr EA, et al. Perfluoroalkyl acids in maternal serum and indices of fetal growth: the Aarhus Birth Cohort. Environ Health Perspect 2016;124(6):848-854.
16. Lenters V, Portengen L, Rignell-Hydbom A, et al. Prenatal phthalate, perfluoroalkyl acid, and organochlorine exposures and term birth weight in three birth cohorts: multi-pollutant models based on elastic net regression. Environ Health Perspect 2016;124(3):365-372.
17. Kishi R, Nakajima T, Goudarzi H, et al. The association of prenatal exposure to perfluorinated chemicals with maternal essential and long-chain polyunsaturated fatty acids during pregnancy and the birth weight of their offspring: the Hokkaido Study. Environ Health Perspect 2015;123(10):1038-1045.
18. Darrow LA, Stein CR, Steenland K. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the mid-Ohio Valley, 2005-2010. Environ Health Perspect 2013;121(10):1207-1213.
19. Whitworth KW, Haug LS, Baird DD, et al. Perfluorinated compounds in relation to birthweight in theNorwegian Mother and Child Cohort Study. Am J Epidemiol 2012;175(12):1209-1216.
20. Johnson PI, Sutton P, Atchley DS, et al. The Navigation Guide-evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect 2014; 122(10):1028-1039.
21. Hamm MP, Cherry NM, Chan E, et al. Maternal exposure to perfluorinated acids and fetal growth. J Expo Sci Environ Epidemiol 2010;20(7):589-597.
22. Savitz DA, Stein CR, Bartell SM, et al. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 2012;23(3):386-392.
23. Savitz DA, Stein CR, Elston B, et al. Relationship of perfluorooctanoic acid exposure to pregnancy outcome based on birth records in the mid-Ohio Valley. Environ Health Perspect 2012;120(8):1201-1207.
24. Nolan LA, Nolan JM, Shofer FS, et al. The relationship between birth weight, gestational age and perfluorooctanoic acid (PFOA)-contaminated public drinking water. Reprod Toxicol 2009;27(3-4):231-238.
25. Lee ES, Han S, Oh JE. Association between perfluorinated compound concentrations in cord serum and birth weight using multiple regression models. Reprod Toxicol 2016;59:53-59.
26. Savitz DA. Biomarkers of perfluorinated chemicals and birth weight [editorial]. Environ Health Perspect 2007;115(11): A528-A529.
27. Savitz DA. Invited commentary: interpreting associations between exposure biomarkers and pregnancy outcome. Am J Epidemiol 2014;179(5):545-547.
28. Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998;54(6):2056-2063.
29. Shankar A, Xiao J, Ducatman A. Perfluoroalkyl chemicals and chronic kidney disease in US adults. Am J Epidemiol 2011; 174(8):893-900.
30. Watkins DJ, Josson J, Elston B, et al. Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ Health Perspect 2013;121(5):625-630.
31. Morken NH, Travlos GS, Wilson RE, et al. Maternal glomerular filtration rate in pregnancy and fetal size. PLoS One 2014;9(7):e101897.
32. Wang Z, Cousins IT, Scheringer M, et al. Global emission inventories for C4-C14 perfluoroalkyl carboxylic acid (PFCA) homologues from 1951 to 2030, part II: the remaining pieces of the puzzle. Environ Int 2014;69:166-176.
33. Oken E, Baccarelli AA, Gold DR, et al. Cohort profile: Project Viva. Int J Epidemiol 2015;44(1):37-48.
34. Kato K, Basden BJ, Needham LL, et al. Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals. J Chromatogr A 2011;1218(15): 2133-2137.
35. Kuklenyik Z, Needham LL, Calafat AM. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem 2005;77(18): 6085-6091.
36. Hornung RW, Reed LW. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990;5(1):46-51.
37. Sagiv SK, Rifas-Shiman SL, Webster TF, et al. Sociodemographic and perinatal predictors of early pregnancy per-and polyfluoroalkyl substance (PFAS) concentrations. Environ Sci Technol 2015;49(19):11849-11858.
38. Oken E, Kleinman KP, Rich-Edwards J, et al. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6.
39. Phillips G, Brett K, Mendola P. Previous breastfeeding practices and duration of exclusive breastfeeding in the United States. Matern Child Health J 2011;15(8):1210-1216.
40. D'eon JC, Simpson AJ, Kumar R, et al. Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy. Environ Toxicol Chem 2010;29(8):1678-1688.
41. Agency for Toxic Substances and Disease Registry. Toxicological profile for perfluoroalkyls. (Draft for public comment). 2015. https://www. atsdr. cdc. gov/toxprofiles/TP. asp?id=1117&tid=237. Accessed December 21, 2017.
42. Environmental Protection Agency. Risk management for perand polyfluoroalkyl substances (PFASs) under TSCA. PFOA Stewardship Program. 2006. https://www. epa. gov/assessing-andmanaging-chemicals-under-tsca/and-polyfluoroalkyl-substancespfass-under-tsca#tab-3. Accessed September 12, 2016.
43. Kato K, Wong LY, Jia LT, et al. Trends in exposure to polyfluoroalkyl chemicals in the US population: 1999-2008. Environ Sci Technol 2011;45(19):8037-8045.
44. Centers for Disease Control and Prevention. Fourth Report on Human Exposure to Environmental Chemicals: Updated Tables. Atlanta, GA: Centers for Disease Control and Prevention; 2009. http://www. cdc. gov/exposurereport/. Accessed December 21, 2017.
45. Lau C, Anitole K, Hodes C, et al. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol Sci 2007; 99(2):366-394.
46. DeWitt JC, ed. Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances. New York, NY: Springer Publishing Company; 2015.
47. Vanden Heuvel JP, Thompson JT, Frame SR, et al. Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-?,-?, and-?, liver X receptor-?, and retinoid X receptor-?. Toxicol Sci 2006; 92(2):476-489.
48. Knox SS, Jackson T, Frisbee SJ, et al. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project. J Toxicol Sci 2011;36(4):403-410.
49. DeWitt JC, Shnyra A, Badr MZ, et al. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 2009;39(1):76-94.
50. Verner MA, Loccisano AE, Morken NH, et al. Associations of perfluoroalkyl substances (PFAS) with lower birth weight: an evaluation of potential confounding by glomerular filtration rate using a physiologically based pharmacokinetic model (PBPK). Environ Health Perspect 2015;123(12):1317-1324.
51. Shi Y, Yang L, Li J, et al. Occurrence of perfluoroalkyl substances in cord serum and association with growth indicators in newborns from Beijing. Chemosphere 2017;169: 396-402.
52. Fromme H, Mosch C, Morovitz M, et al. Pre-and postnatal exposure to perfluorinated compounds (PFCs). Environ Sci Technol 2010;44(18):7123-7129.